Christina (@workingtoendms) 's Twitter Profile
Christina

@workingtoendms

Sr. Mgr of Public Policy Advocacy in MN & WI for the Nat'l Multiple Sclerosis Society. Seasoned Public Affairs Professional. My tweets are my own. ✝️

ID: 1557813223910526977

calendar_today11-08-2022 19:36:37

1,1K Tweet

146 Followers

346 Following

kenthemser (@kenthemser) 's Twitter Profile Photo

I have no dexterity. Can't type or hold glasses. Can't walk. My wife feeds me. Dresses me. Pretty much everythings me. Life is hard at times for MSers. Perspective and humor are keys. Fight on! And smile. #MS #MultipleSclerosis. #LifewithMS #ChronicIllness #MSwarrior #MSawareness

I have no dexterity. Can't type or hold glasses. Can't walk. My wife feeds me. Dresses me. Pretty much everythings me. Life is hard at times for MSers. Perspective and humor are keys. Fight on! And smile.
#MS #MultipleSclerosis. #LifewithMS #ChronicIllness #MSwarrior #MSawareness
Christina (@workingtoendms) 's Twitter Profile Photo

Fully-accessible resort, first of its kind, opens in Ely, Minnesota! #AmericansWithDisabilitiesAct #ADA mprnews.org/episode/2024/0…

Fully-accessible resort, first of its kind, opens in Ely, Minnesota! #AmericansWithDisabilitiesAct #ADA mprnews.org/episode/2024/0…
Christina (@workingtoendms) 's Twitter Profile Photo

I just registered for the upcoming #MSActivist Webinar: "Voting Without Barriers!" I hope you'll join me for the virtual event! Register today at: p2a.co/la0IHFZ

Christina (@workingtoendms) 's Twitter Profile Photo

Patient liability, treatment adherence, and treatment persistence associated with state bans of copay accumulator adjustment programs | Journal of Managed Care & Specialty Pharmacy jmcp.org/doi/10.18553/j…

Christina (@workingtoendms) 's Twitter Profile Photo

This study found that in states making #AllCopaysCount, patients paid 41%-63% less for their medicine. They were also more likely to keep taking their medicine correctly and less likely to stop taking it. #WILEG #MNLEG jmcp.org/doi/10.18553/j…

Christina (@workingtoendms) 's Twitter Profile Photo

WOW --> "Copay accumulators were initially focused in specific specialty therapeutic areas, such as autoimmune diseases or #multiplesclerosis; however, use has expanded to other diseases as well". Isn't that discrimination & denial of care?jmcp.org/doi/10.18553/j…

Rep. Jake Auchincloss 🟧 (@repauchincloss) 's Twitter Profile Photo

Update: CVS Caremark is now charging $7,636 for a $17 multiple sclerosis drug. CVS Health why are you marking up this MS drug by a record 47,000%? #PharmacistsFightBack

Corbin P McGhee (@mcgheecorbin) 's Twitter Profile Photo

Literally just testified about this yesterday for the Illinois House Committee on Healthcare Availability & Accessibility. Something has to be done. These back room deals that PBMs are directly impacting the wallets of patients. It’s time for #PBMReform! #MSActivist

MS Activist (@msactivist) 's Twitter Profile Photo

Thank you Rep. Jake Auchincloss 🟧 for continuing to highlight the issues of access & affordability of MS meds. The availability of generic disease-modifying meds should mean greater affordability for those with MS. 🚨The time for #PBMReform is now!🚨 #MSActivist

Rep. Jake Auchincloss 🟧 (@repauchincloss) 's Twitter Profile Photo

Good question - I introduced the bipartisan Pharmacists Fight Back Act to block PBM price-gouging abuses that raise premiums & co-pays and bankrupt community pharmacies. How you can help: call your Member of Congress & encourage them to co-sponsor the #PharmacistsFightBack Act.

Rep. Jake Auchincloss 🟧 (@repauchincloss) 's Twitter Profile Photo

I’m up against the lobby for PBMs. I need 25 Ds & 25 Rs signed on by Thanksgiving — call your Member of Congress & ask them to sponsor the Pharmacists Fight Back Act, HR 9096. Use the hashtag #PharmacistsFightBack with the most appalling Rx drug markup you’ve seen. Keep the

Rachel Horne (@rachelhorne19) 's Twitter Profile Photo

The FDA, the US Food & Drug Administration, has approved the use of Ocrevus as a 2x/year '10 minute injection' vs an hours-long infusion. Ocrevus treats relapsing & primary progressive MS. This week a woman in Wales was the 1st in UK to get the injection. bbc.com/news/articles/…

Lisa Doggett (@lisadoggettmd) 's Twitter Profile Photo

We are celebrating with other #MSwarriors and supporters at US Bank Stadium in #Minneapolis after two glorious days of #biking . Thanks to the ⁦National MS Society⁩ for making the 2024 Tour of Champions a great success! #multiplesclerosis #IRideWithMS

We are celebrating with other #MSwarriors and supporters at US Bank Stadium in #Minneapolis after two glorious days of #biking . Thanks to the ⁦<a href="/mssociety/">National MS Society</a>⁩ for making the 2024 Tour of Champions a great success! #multiplesclerosis #IRideWithMS
Multiple Sclerosis News Today (@msnewstoday) 's Twitter Profile Photo

The FDA approved Ocrevus Zunovo, a subcutaneous formulation of Ocrevus, for adults with relapsing forms of MS and PPMS bit.ly/3XkuP5e #news

The FDA approved Ocrevus Zunovo, a subcutaneous formulation of Ocrevus, for adults with relapsing forms of MS and PPMS bit.ly/3XkuP5e #news